Galera Therapeutics, Inc. 8-K

What Happened

• Galera Therapeutics, Inc. (GRTX) announced on July 7, 2026 (8-K, Item 8.01) that its board approved a one-for-two hundred (1:200) reverse stock split of its common stock. The Reverse Stock Split is expected to become effective July 12, 2026 at 11:59 p.m. Eastern Time, with shares trading on a split-adjusted basis starting at market open on July 13, 2026. The filing was signed by J. Mel Sorensen, M.D., President and CEO.

Key Details

• Ratio: 1-for-200 reverse split — every 200 existing shares will convert into 1 post-split share.
• Effective timing: Effective July 12, 2026 at 11:59 p.m. ET; adjusted trading begins July 13, 2026.
• Fractional shares: No fractional shares will be issued; holders entitled to fractions will receive cash in lieu equal to the fraction multiplied by the closing OTCQB price on the last trading day prior to the effective date.
• Equity and derivatives adjustments: The number of shares available under the 2019 Equity Incentive Plan and 2023 Employment Inducement Award Plan, and shares issuable upon exercise of outstanding stock options and warrants, will be reduced proportionately; exercise prices for options and warrants will increase proportionately. Adjustments occur automatically at effectiveness.

Why It Matters

• The reverse split will materially reduce the number of outstanding shares (200-to-1) and raise the per-share price proportionately.
• Outstanding stock options, warrants and shares available under equity plans will be adjusted automatically on a proportionate basis, affecting share counts and exercise prices for holders.
• Holders of fractional post-split shares will receive cash instead of fractional stock, based on the OTCQB closing price before the split becomes effective.

Keywords: reverse stock split, Galera Therapeutics, OTCQB, options, warrants, equity incentive plan, fractional shares, 1-for-200.